SONOMA PHARMACEUTICALS, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent of 0.00% for the 12-month period ending 2020-03-31, per its 10-K filed 2020-07-10.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment · last filed 2020-07-10
- SONOMA PHARMACEUTICALS, INC. effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2020 was 0.00%, a 100.00% decline from fiscal 2019.
- SONOMA PHARMACEUTICALS, INC. effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2019 was 0.60%.
- SONOMA PHARMACEUTICALS, INC. effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2018 was -0.30%.
- SONOMA PHARMACEUTICALS, INC. effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2017 was -0.30%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent 12 month as first filed |
|---|---|---|
| 2020-03-31 | 0.00% 10-K · filed 2020-07-10 | |
| 2019-03-31 | 0.60% 10-K · filed 2020-07-10 | -0.60% 10-K · filed 2019-07-01 |
| 2018-03-31 | -0.30% 10-K · filed 2019-07-01 | |
| 2017-03-31 | -0.30% 10-K · filed 2018-06-26 | |
| 2016-03-31 | -0.40% 10-K · filed 2017-06-28 | 0.40% 10-K · filed 2016-06-21 |
| 2015-03-31 | 0.20% 10-K · filed 2016-06-21 | -0.20% 10-K · filed 2015-06-16 |
| 2014-03-31 | 0.10% 10-K · filed 2015-06-16 | |
| 2013-03-31 | -1.40% 10-K · filed 2014-06-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |